Increase in Xaa-Pro peptidase levels may indicate proteolytic activity (i.e., breakdown of ECM components), leading to renal structural injury seen in DN. Decreased MUP1 suggests a potential dysregulation of this protein, leading to altered renal function and impaired antioxidant defense mechanisms. This evidence concerns the gene SLC25A19 and liver dysplastic nodule.